CMF regimen

CMF regimen

Oncology An adjuvant combination–cyclophosphamide, MTX, fluorouracil–regimen administered after modified radical mastectomy in lymph node-positive breast CA. See Breast cancer.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
* The CMF regimen involves cyclophosphamide 100 mg/[m.sup.2] given orally on days 1-14; methotrexate in doses of 40 mg/[m.sup.2] via IV on days 1 and 8; and 5-fluorouracil 600 mg/[m.sup.2] given by IV on days 1 and 8, repeated every 28 days for a total of six cycles.
No evidence of 'chemobrain' seen in small sample of breast cancer patients
Darby and his colleagues looked at a total of 30 women who had already undergone either lumpectomy or mastectomy and were scheduled to undergo either the chemotherapy regimen known as AC (n = 15) or CEF or CMF regimens (n = 15).
'Chemobrain' not seen in breast cancer therapy
The second wave of trials compared anthracycline-based regimens with CMF regimens. The relative risk of recurrence was reduced by a further 16% with anthracycline regimens, compared with CMF, in women younger than 50, and by 11% in those aged 50-69.
Breast ca leads drop in U.S., U.K. mortality

Medical browser ?
Full browser ?